2013 American Transplant Congress
Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART
Recent data raised question regarding the safety of everolimus (EVR) in the early post-operative period in de novo heart transplant (HT) recipients. Thus, we have…2013 American Transplant Congress
Rejection Phenotypes, Rejection Timing and Kidney Transplant Outcome
University Hospitals Leuven, Leuven, Belgium
BACKGROUNDThe relative impact of different types of T-cell mediated rejection (borderline changes [BAR], grade 1 or grade 2-3 T-cell mediated rejection [TCMR]) and of antibody-mediated…2013 American Transplant Congress
C1q-Fixing Human Leukocyte Antigen Antibodies Identified by a C1q Assay Are Associated with Acute and Chronic Rejection in HLA-IgG Positive Kidney Transplant Recipients
Background: Although donor-specific HLA antibodies (DSA) are associated with antibody-mediated rejection (AMR) and poor clinical outcome in kidney transplantation, not all DSAs are harmful to…2013 American Transplant Congress
Should All Type 1 Diabetic Patients (T1DM) Undergo Cardiac Angiography for Transplant Evaluation?
Transplant Surgery, UW Madison, Madison, WI
Objectives: Cardiovascular disease is the leading cause of death after transplantation. Optimal work-up remains controversial. Since 2005, we have performed cardiac catheterization for all T1DM…2013 American Transplant Congress
Face Transplantation with Combined Hematopoietic Stem Cell Infusion and Vascularized Bone Marrow Transplantation Is Not Associated with Mixed Chimerism in Humans
In rat models of limb allograft transplantation, the combination of vascularized bone marrow transplantation (VBMT) with both Csa and anti-TCR mAb is associated with the…2013 American Transplant Congress
Candidate to Renal Transplant Evaluation: Difficulties in the Access to the Waiting List
Unidad de Trasplante Renal, CRAI SUR, HIGA San Martin, La Plata, Buenos Aires, Argentina
Background: The selection of candidates for kidney transplantation remains a challenge due to complex medical and social situations. There is a progressive increase in the…2013 American Transplant Congress
Alemtuzumab Mitigates the Risk of Early Rejection Associated with Delayed Graft Function in Deceased Donor Renal Transplantation
Imperial College Kidney and Transplant Centre, London, United Kingdom
Delayed graft function [DGF] is associated with rejection [AR] and allograft loss. It is postulated that ischaemic injury up regulates the expression of allograft MHC…2013 American Transplant Congress
Chimerism and Tolerance without GVHD in Mismatched Recipients of Combined Hematopoietic Stem Cell/Kidney Transplants: Donor-Specific Hyporeactivity Is Not a Reliable Biomarker for Tolerance
We recently reported that low-intensity conditioning combined with facilitating cell (FC)-enriched hematopoietic stem cell transplantation (FCRx) can safely achieve high level, durable donor chimerism in…2013 American Transplant Congress
Evaluation of Non-Adherence in Patients Undergoing Dialysis, Pre- and Post-Kidney Transplantation: US Transplant Practice Patterns Survey
Introduction: We carried out a survey of US transplant centers to evaluate practice patterns in the assessment of non-adherence before and after kidney transplantation.Methods: An…2013 American Transplant Congress
When Next of Kin Don't Want Their Deceased Family Members To Donate: A Survey of U.S. Organ Procurement Organizations (OPOs)
Background: The legal concept of First Person Authorization is based on the principle that the decision to donate by a person with decision-making capacity should…
American Transplant Congress abstracts